Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.4.0.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities    
Net loss $ (348,974) $ (335,844)
Adjustments to reconcile net loss to net cash used in operating activities:    
Non-cash LNG inventory write-downs 216 17,502
Depreciation and amortization expense 24,089 17,769
Share-based compensation 16,171 16,140
Amortization of debt issuance costs and discount 12,817 9,116
Loss on early extinguishment of debt 1,457 88,992
Total losses on derivatives, net 182,169 126,183
Net cash used for settlement of derivative instruments (8,817) (37,262)
Impairment expense 10,166 176
Other 303 8,627
Changes in restricted cash for certain operating activities 43,366 75,233
Changes in operating assets and liabilities:    
Accounts and interest receivable 1,092 (28,083)
Inventory (1,531) (29,676)
Accounts payable and accrued liabilities (27,831) 73,002
Deferred revenue (1,000) (1,003)
Other, net 7,617 (15,052)
Net cash used in operating activities (88,690) (14,180)
Cash flows from investing activities    
Property, plant and equipment, net (1,149,827) (590,998)
Use of restricted cash for the acquisition of property, plant and equipment 1,151,073 572,623
Other (17,861) (46,164)
Net cash used in investing activities (16,615) (64,539)
Cash flows from financing activities    
Proceeds from issuances of debt 1,908,000 2,500,000
Repayments of debt (415,000) 0
Debt issuance and deferred financing costs (49,307) (58,395)
Investment in restricted cash (1,423,595) (1,929,288)
Distributions and dividends to non-controlling interest (20,098) (20,050)
Proceeds from exercise of stock options 0 958
Payments related to tax withholdings for share-based compensation (976) (3,771)
Other 2 20
Net cash provided by (used in) financing activities (974) 489,474
Net increase (decrease) in cash and cash equivalents (106,279) 410,755
Cash and cash equivalents—beginning of period 1,201,112 1,747,583
Cash and cash equivalents—end of period $ 1,094,833 $ 2,158,338